Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04131049
Other study ID # 8811
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 24, 2019
Est. completion date January 24, 2020

Study information

Verified date February 2021
Source TC Erciyes University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to compare the impact of carbohydrate counting (CC) method which is standard insulin dose calculation algorithm and food insulin index (FII) method which is a new algorithm on postprandial glucose following a high fat and a high protein meal in adolescent with type 1 diabetes. A randomized, single-blind and crossover trial included 14 adolescents aged 14-18 years with type 1 diabetes. All participants were sent to their homes for 4 consecutive days with a different glycemic index breakfast. The insulin doses of the meals were calculated according to CC and FII methods. Test breakfasts with different GIs and insulin requirements calculated with different algorithms are as follows: High GI calculated by CC (CHGI), low GI calculated by CC (CLGI), high GI calculated by FII (FHGI) and low GI calculated by FII (FLGI).


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date January 24, 2020
Est. primary completion date November 24, 2019
Accepts healthy volunteers No
Gender All
Age group 14 Years to 18 Years
Eligibility Inclusion Criteria: - Aged between 14-18 years adolescents - Type 1 diabetes diagnosed for at least one year - Performing self-monitoring of blood glucose and doses of insulin at least four times daily - HbA1c = 9.6% for the last three months - Negative fasting C-peptide (<0.1 nmol/L) - Total daily insulin use of = 0.5 U/kg - World Health Organization BMI/age z-score of -1 to below 3 Exclusion Criteria: - Complications of diabetes or other medical conditions including celiac disease - Treatment with oral hypoglycaemic agents - Food allergies, intolerances, or eating disorder - Intestinal malabsorptions - Delayed gastric emptying - Viral or bacterial infection - Physical or mental disability - Clinical condition related to impaired digestive system such as cystic fibrosis

Study Design


Related Conditions & MeSH terms


Intervention

Other:
High GI calculated by CC (CHGI)
This test meal with high GI were served as a breakfast after 8-hours fasting and participants were asked to consume the meal in full, within 20 min.
Low GI calculated by CC (CLGI)
This test meal with low GI were served as a breakfast after 8-hours fasting and participants were asked to consume the meal in full, within 20 min.
High GI calculated by FII (FHGI)
This test meal with high GI were served as a breakfast after 8-hours fasting and participants were asked to consume the meal in full, within 20 min.
Low GI calculated by FII (FLGI)
This test meal with low GI were served as a breakfast after 8-hours fasting and participants were asked to consume the meal in full, within 20 min.

Locations

Country Name City State
Turkey Erciyes University Faculty of Health Sciences Kayseri

Sponsors (1)

Lead Sponsor Collaborator
TC Erciyes University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Postprandial glucose response by glucometer Postprandial glucose response was quantified as incremental area under the curve (iAUC) (mg/dL x minutes), which was calculated according to the trapezoidal rule by using blood glucose values at time points 0, 30, 60, 90, 120, 150, 180, 210 and 240 minutes. Four hours postprandial period (from fasting to 240 minutes after the test breakfast)
Primary Postprandial glucose response by continous glucose monitoring Postprandial glucose response was quantified as incremental area under the curve (iAUC) (mg/dL x minutes), which was calculated according to the trapezoidal rule by using blood glucose values at time points 0, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100, 105, 110, 115, 120, 125, 130, 135, 140, 145, 150, 155, 160, 165, 170, 175, 180, 185, 190, 195, 200, 205, 210, 215, 220, 225, 230, 235 and 240 minutes. Four hours postprandial period (from fasting to 240 minutes after the test breakfast)
See also
  Status Clinical Trial Phase
Completed NCT03437551 - Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy N/A
Completed NCT05168657 - Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth N/A
Completed NCT01781975 - Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus Phase 2
Completed NCT02307110 - Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy N/A